Association Between Initial Emergency Department Lactate and Use of Vasoactive Medication in Children With Septic

Michael J Miescier1, Roni D Lane1, Xiaoming Sheng2

  • 1From the Division of Pediatric Emergency Medicine, Department of Pediatrics.

Pediatric Emergency Care
|January 10, 2017
PubMed

Insights

Elevated initial serum lactate levels in pediatric septic shock patients are linked to increased need for vasoactive medications. This finding highlights lactate as a key indicator for early intervention in pediatric emergency departments.

Area of Science:

  • Pediatric Emergency Medicine
  • Critical Care
  • Biomarkers

Background:

  • Current pediatric septic shock guidelines prioritize clinical signs for early detection.
  • Elevated serum lactate correlates with mortality in adult septic shock.
  • The role of initial lactate in pediatric septic shock management requires further clarification.

Purpose of the Study:

  • To investigate the association between initial serum lactate levels in pediatric emergency department (PED) patients with septic shock and the subsequent need for vasoactive medication within 24 hours.

Main Methods:

  • Retrospective study of 864 pediatric patients (2008-2012) treated for septic shock in a tertiary care children's hospital.
  • Included patients had serum lactate measured in the PED.
  • Multivariable logistic regression analyzed the relationship between initial lactate and vasoactive medication use.

Main Results:

  • Median initial lactate was 2.1 mmol/L; 14% of patients received vasoactive medication within 24 hours.
  • Lactate levels of 3.1-5 mmol/L (OR 1.82) and ≥5.1 mmol/L (OR 5.00) were associated with increased vasoactive medication use.
  • Hypotension, abnormal pulses, and altered mental status also correlated with vasoactive medication use.

Conclusions:

  • Higher initial serum lactate levels in the pediatric emergency department are significantly associated with the need for vasoactive medication within 24 hours for patients with septic shock.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
628
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
434
Local Anesthetics: Pharmacokinetics01:13

Local Anesthetics: Pharmacokinetics

The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
1.4K